Evidence map›Paper›PMID 24464103›Full record

ArticleBlood cancer journal2014

EVI1 expression in childhood acute lymphoblastic leukaemia is not restricted to MLL and BCR/ABL rearrangements and is influenced by age.

A Stevens, D Hanson, C de Leonibus, A Whatmore, R Donn, D J White, J Liu, M M van den Heuvel-Eibrink, V Saha, P E Clayton and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. LowFrontiers in medicine · 2025
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

A Stevens1] Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK [2] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK.
D Hanson1] Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK [2] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK.
C de Leonibus1] Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK [2] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK.
A Whatmore1] Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK [2] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK.
R Donn1] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK [2] The Centre for Musculoskeletal Research, Manchester, UK.
D J White1] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK [2] Stem Cell and Leukaemia Proteomics Laboratory, Manchester, UK.
J Liu1] Children's Cancer Group, Manchester, UK [2] Institute for Cancer Sciences, University of Manchester, Manchester, UK.
M M van den Heuvel-EibrinkDepartment of Pediatric Hematology and Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
V Saha1] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK [2] Children's Cancer Group, Manchester, UK [3] Institute for Cancer Sciences, University of Manchester, Manchester, UK [4] Tata Translational Cancer Research Centre, Kolkata, India.
P E Clayton1] Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, UK [2] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK.
S Meyer1] Manchester Academic Health Science Centre, University of Manchester, Royal Manchester Children's Hospital, Manchester, UK [2] Stem Cell and Leukaemia Proteomics Laboratory, Manchester, UK [3] Institute for Cancer Sciences, University of Manchester, Manchester, UK [4] Department of Paediatric Oncology, Royal Manchester Children's Hospital, Manchester, UK [5] Young Oncology Unit, The Christie NHS foundation Trust, Manchester, UK.
Erasmus MC - Sophia Children’s Hospital · NL

Funding

Cancer Research UK 14840DBT-Wellcome Trust India Alliance IA/M/12/1/500261
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID24464103
PMCPMC3913945
OpenAlexW2137253891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.